Inventor · disambiguated record
Timothy Kercher
Also filed as: KERCHER TIMOTHY · KERCHER TIMOTHY S · KERCHER TIMOTHY SCOTT
32 granted patents·10 pending applications·289 citations·filing 2006–2024
96Inventor score
Top patents by PatentIndex Score
42 records- 0197US8791123B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsALLEN SHELLEY·Filed 2010·Granted Jul 29, 2014·94 cites·61 claims
- 0296US11185543B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2020·Granted Nov 30, 2021·5 cites·20 claims
- 0396US11149007B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2019·Granted Oct 19, 2021·14 cites·41 claims
- 0496US9796724B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 24, 2017·16 cites·30 claims
- 0596US9782415B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 10, 2017·19 cites·30 claims
- 0695US10357489B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2018·Granted Jul 23, 2019·20 cites·26 claims
- 0794US11325889B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2019·Granted May 10, 2022·11 cites·35 claims
- 0894US8299021B2Macrocyclic inhibitors of hepatitis C virus replicationBLATT LAWRENCE M·Filed 2012·Granted Oct 30, 2012·47 cites·2 claims
- 0993US11873283B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2021·Granted Jan 16, 2024·2 cites·34 claims
- 1093US7829665B2Macrocyclic inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2006·Granted Nov 9, 2010·27 cites·29 claims
- 1189US12209086B2FGFR3 inhibitor compoundsLILLY CO ELI·Filed 2023·Granted Jan 28, 2025·1 cites·44 claims
- 1288US10251889B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Apr 9, 2019·4 cites·18 claims
- 1387US11878976B2FGFR3 inhibitor compoundsLILLY CO ELI·Filed 2022·Granted Jan 23, 2024·1 cites·37 claims
- 1487US9878997B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jan 30, 2018·4 cites·10 claims
- 1587US9562055B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsALLEN SHELLEY·Filed 2012·Granted Feb 7, 2017·8 cites·61 claims
- 1685US7781474B2Inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2007·Granted Aug 24, 2010·7 cites·13 claims
- 1784US9896435B2N-pyrrolidinyl,N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Feb 20, 2018·3 cites·29 claims
- 1882US11358952B2Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2019·Granted Jun 14, 2022·1 cites·21 claims
- 1982US10323022B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 18, 2019·2 cites·26 claims
- 2082US2024207255A1Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2024·Application pending·0 cites
- 2181US12404241B2Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2023·Granted Sep 2, 2025·0 cites·16 claims
- 2280US2024217955A1Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2024·Application pending·0 cites
- 2378US2025122196A1Fgfr3 inhibitor compoundsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 2477US12029738B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2021·Granted Jul 9, 2024·0 cites·23 claims
- 2577US11945804B2Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewithCELGENE CORP·Filed 2022·Granted Apr 2, 2024·0 cites·23 claims
- 2675US7932277B2Peptide inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2008·Granted Apr 26, 2011·2 cites·79 claims
- 2770US10758542B2Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Sep 1, 2020·0 cites·11 claims
- 2870US10351575B2Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of painARRAY BIOPHARMA INC·Filed 2013·Granted Jul 16, 2019·1 cites·48 claims
- 2963US10889589B2Bicyclic urea, thiourea, guanidine and cyanoguanidine compounds useful for the treatment of painARRAY BIOPHARMA INC·Filed 2019·Granted Jan 12, 2021·0 cites·34 claims
- 3063US2019359597A1Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 3162US2009169510A1Novel macrocyclic inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2008·Application pending·0 cites
- 3260US2024368193A1Kras inhibitorsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 3359US10851080B2Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 1, 2020·0 cites·16 claims
- 3458US2009148407A1Novel Macrocyclic Inhibitors of Hepatitis C Virus ReplicationINTERMUNE INC·Filed 2006·Application pending·0 cites
- 3557US2024343736A1Kras inhibitorsLILLY CO ELI·Filed 2024·Application pending·0 cites
- 3653US9790178B2Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Oct 17, 2017·0 cites·6 claims
- 3747US2009155209A1Novel macrocyclic inhibitors of hepatitis c virus replicationBLATT LAWRENCE M·Filed 2008·Application pending·0 cites
- 3845US9822118B2Bicyclic heteroaryl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Nov 21, 2017·0 cites·6 claims
- 3945US9790210B2N-(monocyclic aryl),N'-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Oct 17, 2017·0 cites·10 claims
- 4044US9828360B2Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2013·Granted Nov 28, 2017·0 cites·17 claims
- 4144US2010209391A1Novel inhibitors of hepatitis c virus replicationINTERMUNE INC·Filed 2010·Application pending·0 cites
- 4234US8962596B25,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinasesBURGESS LAURENCE E·Filed 2011·Granted Feb 24, 2015·0 cites·38 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →